Lobe Sciences Ltd logo

Lobe Sciences Ltd

XCNQ:LOBE (Canada)  
C$ 0.02 (0%) Apr 26
At Loss
Market Cap:
C$ 1.58M ($ 1.16M)
Enterprise V:
C$ 1.89M ($ 1.39M)
Volume:
27.00K
Avg Vol (2M):
49.30K
Also Trade In:
Volume:
27.00K
At Loss

Business Description

Description
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -0.31
Debt-to-Equity -0.52
Debt-to-EBITDA -0.24
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -29.59
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 42.1
3-Year EPS without NRI Growth Rate 41.6
3-Year FCF Growth Rate 45.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 59.5
9-Day RSI 54.48
14-Day RSI 52.35
12-1 Month Momentum % -33.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.08
Quick Ratio 0.08
Cash Ratio 0.02
Days Inventory 2920
Days Sales Outstanding 8.05
Days Payable 386170

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -49.1

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 98.53
Operating Margin % -1128.68
Net Margin % -1154.41
FCF Margin % -492.65
ROA % -87.71
ROIC % -97.97

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 10
EV-to-EBIT -1.22
EV-to-EBITDA -1.25
EV-to-Revenue 13.91
EV-to-FCF -2.82
Earnings Yield (Greenblatt) % -81.97
FCF Yield % -42.32

Financials (Next Earnings Date:2024-04-30 Est.)

XCNQ:LOBE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Lobe Sciences Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.136
EPS (TTM) (C$) -0.02
Beta 0.18
Volatility % 47.41
14-Day RSI 52.35
14-Day ATR (C$) 0.001813
20-Day SMA (C$) 0.01925
12-1 Month Momentum % -33.33
52-Week Range (C$) 0.01 - 0.04
Shares Outstanding (Mil) 79.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lobe Sciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Lobe Sciences Ltd Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Lobe Sciences Ltd Frequently Asked Questions

What is Lobe Sciences Ltd(XCNQ:LOBE)'s stock price today?
The current price of XCNQ:LOBE is C$0.02. The 52 week high of XCNQ:LOBE is C$0.04 and 52 week low is C$0.01.
When is next earnings date of Lobe Sciences Ltd(XCNQ:LOBE)?
The next earnings date of Lobe Sciences Ltd(XCNQ:LOBE) is 2024-04-30 Est..
Does Lobe Sciences Ltd(XCNQ:LOBE) pay dividends? If so, how much?
Lobe Sciences Ltd(XCNQ:LOBE) does not pay dividend.

Press Release

Subject Date
No Press Release